{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T03:36:27Z","timestamp":1789184187067,"version":"build-2803163510"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T00:00:00Z","timestamp":1774224000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100015866","name":"Government of the Basque Country Department of Education Linguistic Policy and Culture","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015866","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014440","name":"Gobierno de Espa\u00f1a Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014440","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.ejmech.2026.118782","type":"journal-article","created":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T17:08:29Z","timestamp":1774285709000},"page":"118782","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Synthesis and biological evaluation of novel fused pyridopyrimidine derivatives as topoisomerase I inhibitors and as potential antitumor agents: promising results in lung, ovary and gastric cancer"],"prefix":"10.1016","volume":"310","author":[{"given":"Leyre","family":"Lopez-Aguileta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Endika","family":"Mart\u00edn-Encinas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Birgitta R.","family":"Knudsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cinzia","family":"Tesauro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annalisa","family":"Schirizzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosangela","family":"Montanaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosalba","family":"D'Alessandro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Grazia","family":"Perrone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Stefanachi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marialessandra","family":"Contino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0866-3493","authenticated-orcid":false,"given":"Concepcion","family":"Alonso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2026.118782_bib1","series-title":"Global Cancer Burden Growing, Amidst Mounting Need for Services","year":"2024"},{"key":"10.1016\/j.ejmech.2026.118782_bib2","series-title":"GLOBOCAN: Cancer Today","year":"2025"},{"key":"10.1016\/j.ejmech.2026.118782_bib3","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/nrm.2016.111","article-title":"Roles of eukaryotic topoisomerases in transcription, replication and genomic stability","volume":"17","author":"Pommier","year":"2016","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.ejmech.2026.118782_bib4","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1146\/annurev.biochem.70.1.369","article-title":"DNA Topoisomerases: Structure, Function, and Mechanism","volume":"70","author":"Champoux","year":"2001","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.ejmech.2026.118782_bib5","series-title":"Topoisomerases and Cancer","author":"Pommier","year":"2012"},{"key":"10.1016\/j.ejmech.2026.118782_bib6","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1080\/17460441.2022.2055545","article-title":"The design and discovery of topoisomerase I inhibitors as anticancer therapies","volume":"17","author":"Mart\u00edn-Encinas","year":"2022","journal-title":"Expet Opin. Drug Discov."},{"key":"10.1016\/j.ejmech.2026.118782_bib7","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1080\/13543776.2021.1879051","article-title":"A patent review of topoisomerase I inhibitors (2016\u2013present)","volume":"31","author":"Selas","year":"2021","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.ejmech.2026.118782_bib8","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s12032-024-02527-x","article-title":"Camptothecin and its derivatives: advancements, mechanisms and clinical potential in cancer therapy","volume":"41","author":"Kamle","year":"2024","journal-title":"Med. Oncol."},{"key":"10.1016\/j.ejmech.2026.118782_bib9","doi-asserted-by":"crossref","first-page":"2916","DOI":"10.1002\/ejoc.201700258","article-title":"Reliable synthesis of phosphino- and phosphine sulfide-1,2,3,4-tetrahydroquinolines and phosphine sulfide quinolones","author":"Alonso","year":"2017","journal-title":"Eur. J. Org. Chem."},{"key":"10.1016\/j.ejmech.2026.118782_bib10","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.ejmech.2018.10.065","article-title":"Antileishmanial activity of new hybrid tetrahydroquinoline and quinoline derivatives with phosphorus substituents","volume":"162","author":"Tejer\u00eda","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118782_bib11","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.ejmech.2018.02.058","article-title":"Novel topoisomerase I inhibitors. Syntheses and biological evaluation of phosphorus substituted quinolinederivates with antiproliferative activity","volume":"149","author":"Alonso","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118782_bib12","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.ejmech.2018.04.033","article-title":"Substituted 1,5-naphthyridine derivatives as novel antileishmanial agents. Synthesis and biological evaluation","volume":"152","author":"Tejeria","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118782_bib13","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.ejmech.2016.09.017","article-title":"Antileishmanial effect of new indeno-1,5-naphthyridines, selective inhibitors of Leishmaniainfantum type IB DNA topoisomerase","volume":"124","author":"Tejeria","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118782_bib14","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.ejmech.2016.03.031","article-title":"Synthesis and biological evaluation of indeno[1,5]naphthyridines as topoisomerase I (TopI) inhibitors with antiproliferative activity","volume":"115","author":"Alonso","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118782_bib15","doi-asserted-by":"crossref","first-page":"2722","DOI":"10.2174\/1568026614666141215152441","article-title":"Synthesis and Biological Evaluation of 1,5-Naphthyridines as Topoisomerase I Inhibitors. A New Family of Antiproliferative Agents. Curr","volume":"14","author":"Alonso","year":"2014","journal-title":"Top. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118782_bib16","article-title":"11H-Pyrido[2,1-b]quinazolin-11-one: a reversible turn-on\/off fluorescent probe for solution and gas-phase detection of acids or basic amines","volume":"192","author":"Silva Neto","year":"2021","journal-title":"Dyes Pigments"},{"key":"10.1016\/j.ejmech.2026.118782_bib17","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1021\/acs.joc.3c02220","article-title":"Aza-Povarov reaction. A method for the synthesis of fused tetracyclic Chromeno[4,3-d]pyrido[1,2-a]pyrimidines","volume":"89","author":"Mart\u00edn-Encinas","year":"2024","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.ejmech.2026.118782_bib18","doi-asserted-by":"crossref","first-page":"193","DOI":"10.2174\/1568009033481967","article-title":"Taxanes: microtubule and centrosome targets, and cell cycle dependent mechanisms of action","volume":"3","author":"Abal","year":"2003","journal-title":"Curr. Cancer Drug Targets"},{"key":"10.1016\/j.ejmech.2026.118782_bib19","doi-asserted-by":"crossref","first-page":"3323","DOI":"10.3390\/cancers12113323","article-title":"Mechanisms of taxane resistance","volume":"12","author":"Maloney","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.ejmech.2026.118782_bib20","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1021\/jm900743c","article-title":"Perspectives of P-glycoprotein modulating agents in oncology and neurodegenerative diseases: pharmaceutical, biological and diagnostic potentials","volume":"53","author":"Colabufo","year":"2010","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118782_bib21","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1129832","article-title":"The multiple combination of paclitaxel, ramucirumab and elacridar reverses the paclitaxel-mediated resistance in gastric cancer cell lines","volume":"13","author":"Schirizzi","year":"2023","journal-title":"Front. Oncol."},{"key":"10.1016\/j.ejmech.2026.118782_bib22","doi-asserted-by":"crossref","first-page":"135","DOI":"10.3390\/ph17010135","article-title":"Harmaline to human mitochondrial caseinolytic serine protease activation for pediatric diffuse intrinsic pontine glioma treatment","volume":"17","author":"Miciaccia","year":"2024","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.ejmech.2026.118782_bib23","doi-asserted-by":"crossref","DOI":"10.1177\/17588359241229433","article-title":"A prospective phase II single-arm study and predictive factor analysis of Irinotecan as third-line treatment in patients with metastatic gastric cancer","volume":"16","author":"Yu","year":"2024","journal-title":"Ther. Adv. Med. Oncol."},{"key":"10.1016\/j.ejmech.2026.118782_bib26","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(96)00423-1","article-title":"Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings","volume":"23","author":"Lipinski","year":"1997","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejmech.2026.118782_bib27","doi-asserted-by":"crossref","first-page":"3714","DOI":"10.1021\/jm000942e","article-title":"Fast calculation of molecular polar surface area as a sum of fragment-based contributions and its application to the prediction of drug transport properties","volume":"43","author":"Ertl","year":"2000","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118782_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/srep42717","article-title":"SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules","volume":"7","author":"Daina","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2026.118782_bib29","doi-asserted-by":"crossref","first-page":"2950","DOI":"10.1021\/ci300447c","article-title":"In silico prediction of aqueous solubility using simple QSPR models: the importance of phenol and phenol-like moieties","volume":"52","author":"Ali","year":"2012","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.ejmech.2026.118782_bib30","series-title":"Lehninger Principles of Biochemistry","author":"Nelson","year":"2021"},{"key":"10.1016\/j.ejmech.2026.118782_bib31","series-title":"StatPearls","article-title":"Drug clearance","author":"Horde","year":"2023"},{"key":"10.1016\/j.ejmech.2026.118782_bib32","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1344042","article-title":"Synthesis, biological and computational evaluation of novel cyanomethyl vinyl ether derivatives","volume":"15","author":"Mart\u00edn-Encinas","year":"2024","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejmech.2026.118782_bib33","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222312808","article-title":"Cytochrome P450 enzymes and drug metabolism in humans","volume":"22","author":"Zhao","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2026.118782_bib34","doi-asserted-by":"crossref","DOI":"10.1021\/bi980757r","article-title":"Camptothecins inhibit the utilization of hydrogen peroxidein the ligation step of topoisomerase I catalysis","volume":"37","author":"Lisby","year":"1998","journal-title":"Biochemistry"},{"key":"10.1016\/j.ejmech.2026.118782_bib35","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/0378-4347(96)00152-1","article-title":"Separation and functional analysis of eukaryotic DNA topoisomerases by chromatographyand electrophoresis","volume":"684","author":"Knudsen","year":"1996","journal-title":"J. Chromatogr. B Biomed. Appl."},{"key":"10.1016\/j.ejmech.2026.118782_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112843","article-title":"One molecule two goals: a selective P-glycoprotein modulator increases drug transport across gastro-intestinal barrier and recovers doxorubicin toxicity in multidrug resistant cancer cells","volume":"208","author":"Contino","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118782_bib37","doi-asserted-by":"crossref","first-page":"135","DOI":"10.3390\/ph17010135","article-title":"Harmaline to human mitochondrial caseinolytic serine protease activation for pediatric diffuse intrinsic pontine glioma treatment","volume":"17","author":"Miciaccia","year":"2024","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.ejmech.2026.118782_bib38","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1129832","article-title":"The multiple combination of paclitaxel, ramucirumab and elacridar reverses the paclitaxel-mediated resistance in gastric cancer cell lines","volume":"13","author":"Schirizzi","year":"2023","journal-title":"Front. Oncol."},{"key":"10.1016\/j.ejmech.2026.118782_bib39","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1038\/s42255-020-00315-1","article-title":"KRAS-Regulated glutamine metabolism requires UCP2-mediated aspartate transport to support pancreatic cancer growth","volume":"2","author":"Raho","year":"2020","journal-title":"Nat. Metab."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523426002278?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523426002278?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T01:54:37Z","timestamp":1776131677000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523426002278"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":37,"alternative-id":["S0223523426002278"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.118782","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synthesis and biological evaluation of novel fused pyridopyrimidine derivatives as topoisomerase I inhibitors and as potential antitumor agents: promising results in lung, ovary and gastric cancer","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.118782","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"118782"}}